Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase NA 1Phase 4 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Venous Thromboembolism 2Thrombosis 2Thrombocytopenia 2Primary Myelofibrosis 2Lymphoma 2Anemia, Aplastic 2Venous Thrombosis 1Thromboembolism 1Thrombocytosis 1Pulmonary Embolism 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Genetic Diseases, Inborn 1Cytopenia 1Burkitt Lymphoma 1Anemia, Refractory, with Excess of Blasts 1Anemia, Hemolytic, Autoimmune 1Anemia 1

Interventions

apixaban 1Simvastatin 1Observation 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Thrombosis × Classical hematology × Clear all
NCT06886516 2026-04-15

Apixaban in Thrombocytopenia

Beth Israel Deaconess Medical Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT02285738 2019-05-08

Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
17 enrolled
Classical hematology

Neoplasms, Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡